Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
International Journal of Molecular Sciences|July 25, 2019
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?Solène Fernandez, Vanessa Desplat, Arnaud Villacreces, et al.Cancers|February 10, 2021
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid LeukemiaJean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, et al.Idrugs : the Investigational Drugs Journal|January 8, 2009
Laromustine, a sulfonyl hydrolyzing alkylating prodrug for cancer therapyArnaud PigneuxLeukemia Research|December 17, 2011
Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot seriesPatrice Chevallier, Arnaud Pigneux, Nelly Robillard, et al.Journal of Hematology|November 23, 2020
Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective AnalysisNathan Mottal, Nahema Issa, Pierre-Yves Dumas, et al.Ejhaem|January 29, 2025
Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitorGaétan Basile, Jean Galtier, Titouan Cazaubiel, et al.British Journal of Haematology|February 2, 2026
Optical genome mapping detects cryptic high-risk and targetable abnormalities in adult AMLAudrey Bidet, Elodie Laharanne, Manon Dos Santos, et al.British Journal of Haematology|May 7, 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapseLuc Heraudet, Jean Galtier, Simon Favre, et al.Ejhaem|February 26, 2024
Prognostic value of postinduction medullary myeloid recovery by flow cytometry in acute myeloid leukemiaCéline Row, Nicolas Lechevalier, Jean Philippe Vial, et al.Pageof 17